PHILADELPHIA, April 18, 2018 -- Carpenter Technology Corporation (NYSE:CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.18 per share of common stock, payable June 7, 2018, to shareholders of record on May 1, 2018. The ex-dividend date (the date the common stock trades without the dividend) is April 30, 2018.
About Carpenter Technology
Carpenter Technology Corporation is a leading producer and distributor of premium specialty alloys, including titanium alloys, nickel and cobalt based superalloys, stainless steels, alloy steels and tool steels. Carpenter’s high-performance materials and advanced process solutions are an integral part of critical applications used within the aerospace, transportation, medical and energy markets, among other markets. Building on its history of innovation, Carpenter’s powder technology capabilities support a range of next-generation products and manufacturing techniques, including additive manufacturing and 3D Printing. Information about Carpenter can be found at www.cartech.com.
Media Inquiries:
William J. Rudolph, Jr.
+1 610-208-3892
[email protected]
Investor Inquiries:
The Plunkett Group
Brad Edwards
+1 212-739-6740
[email protected]


Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
How Marco Pharma International Preserves German Homeopathic Traditions in America
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth 



